Sigachi Industries Limited — Updates, 04-02-2025: Press Release

Sigachi Industries is enhancing its R&D capabilities by establishing a state-of-the-art facility in Hyderabad, backed by an investment of up to USD 1 Million. This initiative aims to integrate critical API developments and analytical efforts, reinforcing the company’s commitment to innovation and operational efficiency. The new center will employ 15-20 skilled R&D scientists focused on accelerating the development of pharmaceutical solutions for regulated markets, ensuring high-quality outputs that meet international standards.

The strategic investment is expected to support existing and new molecule development, while simultaneously expanding the company’s development pipeline. With plans to deliver an additional six CEPs in the coming months, this initiative signifies a strong commitment to sustainable growth and strengthening Sigachi’s market position. Amit Raj Sinha, the Managing Director and CEO, emphasized the importance of this investment in accelerating development efforts and underpinning the company's long-term growth objectives. Investors should view this expansion as a positive indicator of Sigachi's growth trajectory and market leadership potential.